Abstract

ObjectiveWe aimed to estimate the maximum intervention cost (EMIC) a society could invest in a life-saving intervention at different ages while remaining cost-effective according to a user-specified cost-effectiveness threshold.MethodsNew Zealand (NZ) was used as a case study, and a health system perspective was taken. Data from NZ life tables and morbidity data from a burden of disease study were used to estimate health-adjusted life-years (HALYs) gained by a life-saving intervention. Health system costs were estimated from a national database of all publicly funded health events (hospitalizations, outpatient events, pharmaceuticals, etc.). For illustrative purposes we followed the WHO-CHOICE approach and used a cost-effectiveness threshold of the gross domestic product (GDP) per capita (NZ$45,000 or US$30,000 per HALY). We then calculated EMICs for an “ideal” life-saving intervention that fully returned survivors to the same average morbidity, mortality, and cost trajectories as the rest of their cohort.FindingsThe EMIC of the “ideal” life-saving intervention varied markedly by age: NZ$1.3 million (US$880,000) for an intervention to save the life of a child, NZ$0.8 million (US$540,000) for a 50-year-old, and NZ$0.235 million (US$158,000) for an 80-year-old. These results were predictably very sensitive to the choice of discount rate and to the selected cost-effectiveness threshold. Using WHO data, we produced an online calculator to allow the performance of similar calculations for all other countries.ConclusionsWe present an approach to estimating maximal cost-effective investment in life-saving health interventions, under various assumptions. Our online calculator allows this approach to be applied in other countries. Policymakers could use these estimates as a rapid screening tool to determine if more detailed cost-effectiveness analyses of potential life-saving interventions might be worthwhile or which proposed life-saving interventions are very unlikely to benefit from such additional research.Electronic supplementary materialThe online version of this article (doi:10.1186/s12963-015-0052-2) contains supplementary material, which is available to authorized users.

Highlights

  • Many countries spend a substantial proportion of their gross domestic product (GDP) on health, e.g., at least 10 % in high-income countries such as New Zealand [1, 2]

  • We present an approach to estimating maximal cost-effective investment in life-saving health interventions, under various assumptions

  • Our online calculator allows this approach to be applied in other countries. Policymakers could use these estimates as a rapid screening tool to determine if more detailed cost-effectiveness analyses of potential life-saving interventions might be worthwhile or which proposed life-saving interventions are very unlikely to benefit from such additional research

Read more

Summary

Introduction

Many countries spend a substantial proportion of their gross domestic product (GDP) on health, e.g., at least 10 % in high-income countries such as New Zealand [1, 2]. The rapid rise in health spending at a rate faster than GDP growth (due to income growth, technological change, population growth, and aging), is unlikely to be tenable in the long term [3,4,5]. In the ideal world policymakers would probably have the results of studies that identified the country-specific willingness-to-pay value that society places on saving a life at different ages. In such an ideal world, they may have a methodologically compatible league table of life-saving and health-gaining interventions – to inform the “ best” intervention to adopt from a costeffectiveness perspective within a government’s available health budget. Most countries are a long way from having such information available, and they often have limited resources for conducting new cost-effectiveness analyses (which can take many months and cost tens of thousands of dollars per intervention modeled)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.